Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for APXZF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2002. Start Trial.
Date Value
June 30, 2026 -0.2724M
March 31, 2026 -4.713M
December 31, 2025 -4.518M
September 30, 2025 -7.656M
June 30, 2025 -0.1739M
March 31, 2025 -0.2747M
September 30, 2024 -0.277M
June 30, 2024 -0.3401M
March 31, 2024 -0.2594M
December 31, 2023 -23.38M
September 30, 2023 -0.3348M
June 30, 2023 -0.2348M
March 31, 2023 -0.1698M
December 31, 2022 -0.8763M
September 30, 2022 -0.1727M
June 30, 2022 -0.2067M
March 31, 2022 0.4145M
December 31, 2021 2.049M
September 30, 2021 46.78M
June 30, 2021 41.27M
March 31, 2021 -0.1559M
December 31, 2020 30.10M
September 30, 2020 -0.0927M
June 30, 2020 -0.0837M
March 31, 2020 -0.0802M
Date Value
December 31, 2019 0.2496M
September 30, 2019 -0.0613M
June 30, 2019 -0.0528M
March 31, 2019 -0.041M
December 31, 2018 0.0117M
September 30, 2018 0.0621M
June 30, 2018 -3.575M
March 31, 2018 0.00
December 31, 2017 0.00
September 30, 2017 0.00
June 30, 2017 0.00
March 31, 2017 0.00
December 31, 2016 -22.09M
September 30, 2016 -0.761M
June 30, 2016 -0.6436M
March 31, 2016 -1.092M
December 31, 2015 -11.00M
September 30, 2015 -0.9558M
June 30, 2015 -0.9389M
March 31, 2015 -0.804M
December 31, 2014 -0.997M
September 30, 2014 -0.9063M
June 30, 2014 -1.130M
March 31, 2014 -0.81M
December 31, 2013 -0.80M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
SyntheticMR AB 3.380M
HealthStream, Inc. -4.011M
Simulations Plus, Inc. 0.01M
CareView Communications, Inc. 0.00
DATATRAK International, Inc. --